Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
DNLI
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
DNLI: Denali Therapeutics Inc. Stock Analysis | finqOS
DNLI
$18.45
+1.37%
Lists
Call DNLI
Denali Therapeutics
DNLI
Back
Lists
Call DNLI
$18.45
+$0.25 · +1.37%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Call DNLI
Loading chart data...
Signal state